Your browser doesn't support javascript.
loading
B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation.
Chakraborty, Supriya; Martines, Claudio; Porro, Fabiola; Fortunati, Ilaria; Bonato, Alice; Dimishkovska, Marija; Piazza, Silvano; Yadav, Brijesh S; Innocenti, Idanna; Fazio, Rosa; Vaisitti, Tiziana; Deaglio, Silvia; Zamò, Alberto; Dimovski, Aleksandar J; Laurenti, Luca; Efremov, Dimitar G.
Afiliação
  • Chakraborty S; Molecular Hematology Unit, International Center for Genetic Engineering and Biotechnology, Trieste, Italy.
  • Martines C; Molecular Hematology Unit, International Center for Genetic Engineering and Biotechnology, Trieste, Italy.
  • Porro F; Molecular Hematology Unit, International Center for Genetic Engineering and Biotechnology, Trieste, Italy.
  • Fortunati I; Molecular Hematology Unit, International Center for Genetic Engineering and Biotechnology, Trieste, Italy.
  • Bonato A; Molecular Hematology Unit, International Center for Genetic Engineering and Biotechnology, Trieste, Italy.
  • Dimishkovska M; Research Center for Genetic Engineering and Biotechnology, Macedonian Academy of Sciences and Arts, Skopje, North Macedonia.
  • Piazza S; Computational Biology Unit, International Center for Genetic Engineering and Biotechnology, Trieste, Italy.
  • Yadav BS; University of Information Science & Technology St Paul the Apostle, Ohrid, North Macedonia.
  • Innocenti I; Department of Hematology, Catholic University Hospital A. Gemelli, Rome, Italy.
  • Fazio R; Molecular Hematology Unit, International Center for Genetic Engineering and Biotechnology, Trieste, Italy.
  • Vaisitti T; Department of Medical Sciences, University of Turin, Turin, Italy; and.
  • Deaglio S; Department of Medical Sciences, University of Turin, Turin, Italy; and.
  • Zamò A; Institute of Pathology, University of Würzburg, Würzburg, Germany.
  • Dimovski AJ; Research Center for Genetic Engineering and Biotechnology, Macedonian Academy of Sciences and Arts, Skopje, North Macedonia.
  • Laurenti L; Department of Hematology, Catholic University Hospital A. Gemelli, Rome, Italy.
  • Efremov DG; Molecular Hematology Unit, International Center for Genetic Engineering and Biotechnology, Trieste, Italy.
Blood ; 138(12): 1053-1066, 2021 09 23.
Article em En | MEDLINE | ID: mdl-33900379

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos B / Leucemia Linfocítica Crônica de Células B / Transdução de Sinais / Transformação Celular Neoplásica / Proteína Supressora de Tumor p53 / Inibidor p16 de Quinase Dependente de Ciclina / Inibidor de Quinase Dependente de Ciclina p15 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos B / Leucemia Linfocítica Crônica de Células B / Transdução de Sinais / Transformação Celular Neoplásica / Proteína Supressora de Tumor p53 / Inibidor p16 de Quinase Dependente de Ciclina / Inibidor de Quinase Dependente de Ciclina p15 Idioma: En Ano de publicação: 2021 Tipo de documento: Article